MacroGenics, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. MGNX has around 3.5M shares in the U.S. ETF market. The largest ETF holder of MGNX is the iShares Russell 2000 ETF (IWM), with approximately 1.04M shares. Investors may also find of interest that the ETF with the largest allocation to MGNX stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 4.63%. On average, U.S. ETFs allocate 0.27% of MGNX to their portfolios.
Additionally, MGNX is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MGNX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 50.29%.